查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451122

靜脈注射解決方案市場報告（按類型（部分腸外營養、全腸外營養）、營養素（碳水化合物、鹽和電解質、礦物質、維生素、氨基酸）和地區）2024-2032

Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2023年全球靜脈注射解決方案市場規模達148億美元。展望未來， IMARC Group預計到2032年市場規模將達到232億美元，2024-2032年複合年成長率（CAGR）為4.9%。慢性病盛行率的增加、老年人口的增加、技術的快速進步、醫療保健設施的不斷擴張、政府和監管機構實施的支持政策以及家庭醫療保健的不斷轉變是推動市場的一些主要因素。

靜脈注射 (IV) 溶液是指用於將液體直接注射到患者血液中的無菌液體。它包括等滲透壓、高滲透壓和低滲透壓解決方案，滿足不同的醫療需求。它們是使用各種成分生產的，例如水、電解質、糖、維生素和藥物。靜脈注射液廣泛用於水合療法、營養支持、藥物傳遞、輸血、化療、疼痛管理、矯正電解質失衡和解毒治療。它們具有多種優勢，例如控制給藥、減少消化系統影響、客製化營養輸送、直接血流路徑和增強恢復支持。

醫院、診所和專科護理中心等醫療機構的快速擴張，為靜脈注射治療創造了更多機會，推動了市場成長。此外，政府和監管機構為確保醫療機構提供高品質靜脈注射解決方案而實施的支持政策正在對市場成長產生積極影響。此外，緊急情況和外科手術中對靜脈注射解決方案的需求不斷成長，也促進了市場的成長。除此之外，家庭醫療保健（患者在自己家中接受治療）的日益轉變正在促進對專業靜脈注射解決方案的需求。除此之外，在全球突發衛生事件（例如流行病）期間快速治療大量患者的產品應用不斷增加，正在促進市場成長。

靜脈解決方案市場趨勢/促進因素：

疾病盛行率不斷增加

糖尿病、心血管疾病、癌症和急性疾病等慢性疾病的盛行率上升，需要靜脈注射治療，這是推動市場成長的重要因素。此外，新出現的全球趨勢，如生活方式的改變、環境因素和遺傳傾向，導致慢性病增加，也是另一個生長誘導因素。此外，一些慢性和急性疾病需要直接將液體、營養物質或藥物注入血液中。據此，靜脈注射解決方案有助於精確輸送必需的營養素和藥物，並確保患者快速康復。此外，它們還可以實現更快、更可控的護理，特別是在危急情況下。

老年人口不斷增加

不斷成長的老年人口對靜脈注射解決方案市場的成長做出了重大貢獻。老齡化人口對各種健康問題和慢性病的高度敏感，通常需要複雜的醫療干預措施，包括靜脈注射治療，正在推動市場成長。此外，免疫系統較弱、器官功能下降以及其他與年齡相關的生理變化使老年人更容易感染和疾病，這些都促進了市場的成長。與此一致的是，靜脈注射解決方案對於提供必要的水合作用、營養和藥物至關重要，確保治療有針對性和有效。此外，廣泛使用靜脈注射溶液來恢復鈉、鉀、鈣和鎂等電解質的不平衡，是另一個生長誘導因子。

科技的快速進步

醫療保健和靜脈注射解決方案生產的技術進步正在促進市場成長。與此一致的是，新技術使得能夠制定更專業的解決方案，滿足特定患者的需求，並提高靜脈注射療法的效率和安全性。此外，輸液幫浦和輸送系統的最新創新使醫療保健提供者能夠更精確和控制地進行治療，這對市場成長產生了積極影響。此外，監測和管理靜脈注射治療的技術突破可降低併發症風險並改善患者預後，這也是另一個生長誘導因素。此外，專注於生物相容性、個人化治療計劃以及人工智慧 (AI) 等整合技術以增強護理的廣泛研發 (R&D) 工作正在支持市場成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球靜脈注射解決方案市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：按類型
  • 市場區隔：按營養素
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 概述
    • 研究與開發
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第 6 章：市場區隔：按類型

  • 部分腸外營養
    • 市場走向
    • 市場預測
  • 全腸外營養
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依營養素

  • 碳水化合物
    • 市場走向
    • 市場預測
  • 鹽和電解質
    • 市場走向
    • 市場預測
  • 礦物質
    • 市場走向
    • 市場預測
  • 維生素
    • 市場走向
    • 市場預測
  • 胺基酸
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 9 章：靜脈溶液製造程序

  • 產品概述
  • 原料要求
  • 製造流程
  • 關鍵成功因素與風險因素

第 10 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Ajinomoto
    • B. Braun Melsungen
    • Baxter International Inc.
    • Grifols
    • Otsuka Pharmaceutical
Product Code: SR112024A891

The global intravenous solutions market size reached US$ 14.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. The increasing prevalence of chronic diseases, rising geriatric population, rapid technological advancements, increasing expansion of healthcare facilities, imposition of supportive policies by governments and regulatory bodies, and rising shift towards home healthcare are some of the major factors propelling the market.

Intravenous (IV) solutions refer to sterile liquids used to administer fluids directly into a patient's bloodstream. It includes isotonic, hypertonic, and hypotonic solutions, catering to different medical needs. They are produced using various ingredients, such as water, electrolytes, sugars, vitamins, and medications. IV solutions are widely used in hydration therapy, nutritional support, medication delivery, blood transfusion, chemotherapy, pain management, correcting electrolyte imbalances, and detoxification treatments. They offer several benefits, such as controlled administration, reduced digestive system impact, tailored nutrient delivery, direct bloodstream access, and enhanced recovery support.

The rapid expansion of healthcare facilities, such as hospitals, clinics, and specialized care centers, which are generating more opportunities for IV treatments, is propelling the market growth. Additionally, the imposition of supportive policies by governments and regulatory bodies to ensure the availability of high-quality intravenous solutions across healthcare facilities is positively influencing the market growth. Furthermore, the growing demand for IV solutions in emergency scenarios and surgical procedures is contributing to the market growth. Apart from this, the increasing shift towards home healthcare, where patients receive treatment in their own homes, is facilitating the demand for specialized IV solutions. Besides this, the rising product application in treating a large number of patients quickly during global health emergencies, such as pandemics, is catalyzing the market growth.

Intravenous Solutions Market Trends/Drivers:

The increasing prevalence of disease

The heightened prevalence of chronic diseases, such as diabetes, cardiovascular ailments, cancer, and acute conditions, which necessitate IV treatments, is a prominent factor propelling the market growth. Furthermore, emerging global trends, such as lifestyle changes, environmental factors, and genetic predispositions, which lead to an increase in chronic conditions, are acting as another growth-inducing factor. Additionally, several chronic and acute illnesses require direct administration of fluids, nutrients, or medications into the bloodstream. In line with this, IV solutions facilitate precise delivery of essential nutrients and medication and ensure quick patient recovery. In addition, they also enable faster, more controlled care, particularly in critical situations.

The rising geriatric population

The rising geriatric population is contributing significantly to the growth of the IV solutions market. The high susceptibility of the aging population to various health issues and chronic conditions, which often require complex medical interventions, including IV therapy, is propelling the market growth. Furthermore, the presence of a weaker immune system, reduced organ functionality, and other age-related physiological changes that make geriatric individuals more prone to infections and diseases are facilitating the market growth. In line with this, IV solutions are vital in providing essential hydration, nutrients, and medications, ensuring that the treatments are targeted and efficient. Moreover, the widespread utilization of IV solutions to restore imbalance in electrolytes, such as sodium, potassium, calcium, and magnesium, is acting as another growth-inducing factor.

The rapid technological advancements

Technological advancements in medical care and the production of IV solutions are contributing to the market growth. In line with this, new technologies are enabling the formulation of more specialized solutions, catering to specific patient needs, and enhancing the efficiency and safety of IV therapies. Furthermore, the recent innovations in infusion pumps and delivery systems, which allow healthcare providers to administer treatments with greater precision and control, are positively influencing the market growth. Additionally, technological breakthroughs in monitoring and managing IV therapies to lower the risk of complications and improve patient outcomes are acting as another growth-inducing factor. Moreover, extensive research and development (R&D) efforts focusing on biocompatibility, personalized treatment plans, and integrating technology, such as artificial intelligence (AI), to augment care are supporting the market growth.

Intravenous Solutions Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intravenous solutions market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on type and nutrients.

Breakup by Type:

Partial Parenteral Nutrition

Total Parenteral Nutrition

Total parenteral nutrition dominates the market

The report has provided a detailed breakup and analysis of the market based on type. This includes partial parenteral nutrition and total parenteral nutrition. According to the report, total parenteral nutrition represented the largest segment.

Total parenteral nutrition (TPN) is dominating the market as it is used to fulfill all the nutritional requirements of patients who cannot eat or absorb enough food through regular digestive means. Additionally, it finds extensive applications across various medical fields, including oncology, gastroenterology, and intensive care units (ICUs). Furthermore, the rising number of chronic conditions, such as cancer and gastrointestinal diseases, that necessitate the use of TPN for nutritional support is propelling the market growth. Apart from this, increasing utilization of TPN to meet the nutritional needs of patients undergoing major surgical procedures is catalyzing the market growth. Moreover, the recent improvements in TPN formulation and administration technology, ensuring safer and more personalized nutrition support, are strengthening the market growth.

Breakup by Nutrients:

Carbohydrates

Salts and Electrolytes

Minerals

Vitamins

Amino Acids

A detailed breakup and analysis of the market based on the nutrients has also been provided in the report. This includes carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.

Carbohydrates serve as a primary energy source for the human body. They are essential in providing immediate energy, particularly for patients unable to consume food orally. In addition, they are used by all cells in the body, which makes them suitable for a diverse range of patients, irrespective of their specific conditions. Furthermore, carbohydrates can be easily administered through IV solutions, allowing for controlled delivery.

Minerals, such as magnesium, calcium, potassium, and sodium, play critical roles in maintaining various bodily functions, including muscle contraction, nerve transmission, and maintaining fluid balance. Furthermore, IV solutions with specific mineral compositions are essential in correcting electrolyte imbalance, restoring normal cellular function, and stabilizing the patient. Apart from this, minerals are utilized in various medical scenarios, from emergency care to post-operative recovery and chronic disease management.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest intravenous solutions market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America hosts one of the world's most advanced healthcare systems comprising state-of-the-art medical facilities equipped with cutting-edge technology that is fostering a conducive environment for the utilization of IV solutions. Additionally, the region's healthcare spending is among the highest globally, enabling greater access to quality medical care, including treatments requiring intravenous solutions. Furthermore, the implementation of a comprehensive regulatory framework by the regional governments to ensure that IV solutions meet strict quality and safety standards is boosting the market growth. Apart from this, the high prevalence of chronic conditions like diabetes, heart disease, and cancer, which necessitates regular medical interventions, is acting as another growth-inducing factor. Besides this, North America has a strong network of universities, research institutions, and pharmaceutical companies that are actively investing in developing new intravenous solutions and improving existing ones.

Competitive Landscape:

The major players are focusing on creating advanced intravenous products, such as the formulation of new solutions with improved efficiency, the integration of innovative technologies like smart infusion pumps, and the development of personalized therapies. In addition, they are expanding their reach into these regions by setting up new manufacturing facilities, partnering with local distributors, and adapting products to meet specific regional needs. Furthermore, leading companies are engaging in mergers and acquisitions to diversify their product portfolios, leverage synergies, and expand their geographical presence. Moreover, they are placing strong emphasis on quality control and regulatory compliance to ensure that their products meet all relevant safety and efficacy standards. Besides this, top companies in the IV solutions market are focusing on environmentally responsible manufacturing processes and materials by reducing waste and energy consumption and using sustainable resources.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Ajinomoto Co., Inc.

B. Braun Melsungen AG

Baxter International, Inc.

Grifols S.A.

Otsuka Pharmaceutical.

Recent Developments:

In February 2022, B. Braun Medical has obtained approval from the U.S. Food and Drug Administration to commence activities at its recently established manufacturing facility for IV saline solutions located in Daytona Beach, Florida.

In July 2021, Grifols S.A. announced the establishment of an intravenous (IV) solutions production plant in Nigeria.

In March 2022, Otsuka Pharmaceutical. received regulatory approval in Japan for the sale of SAMTASU intravenous infusion for treating cardiac edema.

Key Questions Answered in This Report

  • 1. What is the expected growth rate of the global intravenous solutions market during 2024-2032?
  • 2. What are the key factors driving the global intravenous solutions market?
  • 3. What has been the impact of COVID-19 on the global intravenous solutions market?
  • 4. What is the breakup of the global intravenous solutions market based on the type?
  • 5. What is the breakup of the global intravenous solutions market based on the nutrients?
  • 6. What are the key regions in the global intravenous solutions market?
  • 7. Who are the key players/companies in the global intravenous solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Nutrients
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Partial Parenteral Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Total Parenteral Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Nutrients

  • 7.1 Carbohydrates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Salts and Electrolytes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Minerals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitamins
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Amino Acids
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intravenous Solutions Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Ajinomoto
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 B. Braun Melsungen
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 Baxter International Inc.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Grifols
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Otsuka Pharmaceutical
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2023
  • Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
  • Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
  • Figure 9: Global: Intravenous Solutions Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intravenous Solutions Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Intravenous Solutions Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million US$), 2024-2032
  • Table 4: Global: Intravenous Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Intravenous Solutions: Raw Material Requirements
  • Table 6: Global: Intravenous Solutions Market: Competitive Structure
  • Table 7: Global: Intravenous Solutions Market: Key Players